Key statistics

Is AEHR a good stock to buy in 2026?

Aehr Test Systems (AEHR) presents a complex picture for investors, making the question “is AEHR a good stock” particularly pertinent. While its P/E ratio of -245.38x appears significantly lower than the Semiconductors sector average of 60.3x, indicating potential undervaluation by this metric, its discounted cash flow (DCF) valuation of $-1.51 suggests a substantial overvaluation of -101.7% relative to its current price. Analyst sentiment is mixed, with 33.3% issuing a ‘Buy’ rating, but the overall consensus leans towards ‘Hold’ with a target price that indicates downside. This analysis is for informational purposes only and does not constitute investment advice.

2026 AEHR price scenarios

Based on analyst consensus of $62 from 3 analysts. Not a prediction by Alert Invest.

About Aehr Test Systems (AEHR)

Aehr Test Systems provides test systems for burning-in and testing logic, optical, and memory integrated circuits worldwide. It offers products, such as the ABTS and FOX-P families of test and burn-in systems and FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for lower power and higher power logic devices, as well as various common types of memory devices.

Aehr Test Systems, led by CEO Gayn Erickson, operates with a focused team of 115 employees, specializing in test and burn-in solutions for logic, optical, and memory integrated circuits. The company’s distinctive strengths lie in its proprietary technology, such as the FOX-P and ABTS systems, which are crucial for ensuring the reliability and quality of semiconductors used in high-growth markets like silicon carbide and photonics. This niche expertise allows AEHR to cater to specific, high-demand segments within the broader technology sector, providing a competitive edge despite its relatively smaller size.

AEHR competitive moat and business analysis

Aehr Test Systems operates in a highly specialized segment of the semiconductor industry, offering advanced test and burn-in equipment. While the company’s gross margin of 30.72% indicates some pricing power, its net margin of -25.23% points to significant operational challenges in converting revenue into profit. The absence of reported ROE and ROIC data (N/A) makes it difficult to assess the efficiency of capital deployment and its sustainable competitive advantage from a profitability standpoint, suggesting a lack of clear economic moat based on these metrics alone.

Detailed segment and geographic revenue breakdowns for Aehr Test Systems (AEHR) for fiscal year 2024 are not readily available within the provided data. This lack of granular detail can make it challenging to fully understand the company’s market penetration across different product lines or regions and to identify specific areas of strength or weakness in its operational footprint.

AEHR’s TTM revenue growth stands at a concerning -10.9%, indicating a contracting business rather than an expanding moat. Without any available transcript quotes, it’s difficult to ascertain management’s specific strategies to reverse this trend or articulate a clear path to strengthening its competitive position. The decline suggests the company is facing headwinds in demand or increased competitive pressure, challenging the long-term sustainability of its market position.

When comparing Aehr Test Systems to its peers like AEHR vs AOSL (Alpha and Omega Semiconductor), AEHR vs CEVA, and AEHR vs CTLP (Catalyst Technologies), investors can gain further insight into its market standing. Each of these companies operates within the broader Technology and Semiconductor industries, but with varying product focuses and market strategies. A thorough peer analysis would involve comparing their valuation multiples, growth trajectories, profitability metrics, and competitive advantages to properly contextualize AEHR’s performance and identify potential investment opportunities or risks.

Aehr Test Systems analyst rating

Based on 3 analysts. 33.3% rate AEHR Buy or Strong Buy.

With 33.3% of analysts currently rating AEHR as a ‘Buy’, this figure might not be considered exceptionally strong for the dynamic Technology sector, which often sees higher conviction for growth stocks. Furthermore, the consensus ‘Hold’ rating and a price target indicating significant downside suggest that the broader analyst community remains cautious about AEHR stock’s immediate prospects.

Is AEHR undervalued or overvalued?

Assessing AEHR valuation reveals a complex picture. The company’s P/E ratio stands at a negative -245.38x, contrasting sharply with the Semiconductors sector average of 60.3x. While a negative P/E typically indicates a company is not currently profitable, which would normally imply an expensive stock if there were no earnings, in some contexts it can suggest that the market expects future profitability to normalize this figure, or that other valuation metrics are at play. However, the deep negative value here, combined with negative net margins, points to a clear lack of earnings that complicates straightforward P/E comparisons and raises questions about AEHR stock’s current fundamentals.

Further complicating the AEHR valuation is its discounted cash flow (DCF) fair value of $-1.51, which suggests the stock is currently overvalued by a substantial -101.7%. This indicates that based on its projected future cash flows, the intrinsic value of Aehr Test Systems is significantly below its current trading price. Alongside high P/B (20.18x) and P/S (63.43x) ratios, these metrics collectively suggest that AEHR stock is trading at a premium despite its current unprofitability and declining revenue, urging investors to perform a thorough due diligence before considering whether is AEHR a good stock to add to their portfolio.

AEHR financial health & key metrics

For value investors, the financial health of AEHR Test Systems presents a mixed and generally concerning outlook. While the company boasts a very low debt-to-equity ratio of 0.07x and a strong current ratio of 10.97x, indicating excellent liquidity and minimal reliance on external financing, its profitability metrics are deeply in the red with a net margin of -25.23% and a negative free cash flow yield of -0.4%. Coupled with a -10.9% revenue growth and a negative P/E ratio, the DCF analysis suggests significant overvaluation at $-1.51. These factors combined indicate that AEHR stock might not align with traditional value investment principles focused on strong, consistent earnings and healthy cash generation, despite its robust balance sheet.

Aehr Test Systems earnings history & next report

Aehr Test Systems reported EPS of $-0.05, beating estimates by 37.5%. Next earnings: 2026-07-14 with EPS estimate of $-0.01.

Aehr Test Systems is scheduled to report its next earnings on 2026-07-14, with an estimated EPS of $-0.01. Investors will be keenly watching this report for signs of improvement in the company’s profitability, especially after reporting an EPS of $-0.05 last quarter, which still beat estimates. Key areas to focus on include any commentary from CEO Gayn Erickson regarding revenue stabilization or growth initiatives, progress on margin improvement, and updates on new customer engagements or product pipeline development, as these will be crucial for the future trajectory of AEHR stock.

AEHR daily short volume

Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.

AEHR insider trading activity

Corporate insiders must report trades to the SEC within two business days.

Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice

Recent AEHR analyst rating changes

Aehr Test Systems stock news today

How does AEHR compare to its peers?

For investors considering AEHR stock, examining its direct competitors and alternative investment opportunities within the Technology sector, specifically Semiconductors, can provide valuable context. Understanding how Aehr Test Systems stacks up against similar companies in terms of market position, financial performance, and growth prospects is crucial for informed decision-making. Here’s a look at how AEHR compares to a few of its peers.

FAQ — Aehr Test Systems (AEHR) stock